Morepen Laboratories

Morepen Laboratories to raise over Rs 433 cr via issuance of shares on preferential basis

Morepen Laboratories to raise over Rs 433 cr via issuance of shares on preferential basis

Drug firm Morepen Laboratories on Wednesday said its board has approved raising over Rs 433 crore through issue of shares to Switzerland'...Read More

SAT sets aside Sebi's order in Morepen Laboratories case

SAT sets aside Sebi's order in Morepen Laboratories case

The Securities Appellate Tribunal (SAT) has set aside regulator Sebi's order that had barred Morepen Laboratories from the capital market...Read More

placeholder

Morepen Laboratories goes No.1 globally for bulk drug Montelukast

Morepen Laboratories scores No. 1 position globally for its bulk drug Montelukast

Free Press Journal

www.freepressjournal.in